Skip to content

Gelweave™ 730032ADPRecalls & reported problems

Vascutek Ltd · Gelweave Gelatin Impregnated Woven Vascular Prosthesis VALSALVA · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05037881120140), received between Aug 9, 2018 and Aug 9, 2018 — classified as 2 injuries.

The most frequently reported specific device problem is “Obstruction of Flow” (2 reports).

1 other recall cover devices cleared under the same FDA submission (K013022, K162794); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Obstruction of Flow2

Patient problems

  • Cardiac Arrest2
  • Infarction, Cerebral2
  • Sudden Cardiac Death2
  • Thrombus2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 9, 2018Obstruction of Flow; Obstruction of Flow

    EVENT WAS REPORTED TO VASCUTEK AS FOLLOWS: GELWEAVE VALSALVA GRAFT WAS USED FOR BENTALL PROCEDURE. EXTENSIVE THROMBOSIS OF THE VASCULAR GRAFT OCCURRED FEW HOURS AFTER SURGERY, REQUIRING SURGICAL REVASCULARIZATION. PATIENT DIED OF MASSIVE INFARCTION.

    Patient problems: Cardiac Arrest; Infarction, Cerebral; Sudden Cardiac Death; Thrombus

    MAUDE report 7768055 ↗
  • InjuryAug 9, 2018Obstruction of Flow; Obstruction of Flow

    EVENT WAS REPORTED TO VASCUTEK AS FOLLOWS: GELWEAVE VALSALVA GRAFT WAS USED FOR BENTALL PROCEDURE. EXTENSIVE THROMBOSIS OF THE VASCULAR GRAFT OCCURRED FEW HOURS AFTER SURGERY, REQUIRING SURGICAL REVASCULARIZATION. PATIENT DIED OF MASSIVE INFARCTION.

    Patient problems: Cardiac Arrest; Infarction, Cerebral; Sudden Cardiac Death; Thrombus

    MAUDE report 7768054 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K013022, K162794. One submission often covers many models, so check the product and lot details in each record.

  • Z-2542-2021 · Jul 8, 2021 · Terminated
    The Instructions for Use (IFU) for: Gelsoft Plus Bifurcate, Gelsoft Plus Ax-Fem, GelsoftPlus ERS Ax-Fem, Gelweave Straight, Gelweave Trifurcate, Gelweave Ant-Flo, and Gelweave Val

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page